Sachem Capital Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated March 3, 2022, with a closing date of March 9, 2022, details Sachem Capital Corp.'s entry into a material definitive agreement to issue new debt securities. The Company is a business development company incorporated in New York.
Key Financial Metrics and Transaction Details
- Debt Issuance: The Company sold $50,000,000 aggregate principal amount of 6.00% Notes due March 30, 2027 (Firm Notes).
- Overallotment Option: Underwriters were granted a 30-day option to purchase up to an additional $7,500,000 of Notes.
- Net Proceeds: Expected net proceeds from the Firm Notes are approximately $48.2 million after underwriting discounts, commissions, and estimated offering expenses.
- Interest Rate: 6.00% per annum, payable quarterly in arrears. The first interest payment is due June 30, 2022.
- Underwriting Discount: The Underwriters purchased the Notes at a 3.25% discount.
- Liquidity Impact: The transaction increases the Company's cash position by the net proceeds amount, subject to the use of proceeds not specified in this filing.
Material Changes and Covenants
The filing reports a material increase in the Company's indebtedness. The Notes are unsecured and unsubordinated, ranking equally with existing senior unsecured debt but effectively subordinated to secured indebtedness and structurally subordinated to subsidiary debt. Key covenants include:
- Asset Coverage Ratio: The Company must maintain an Asset Coverage Ratio of at least 150% to pay dividends, make distributions, incur additional indebtedness, or purchase capital stock.
- Dividend Limitation: Dividends or distributions cannot exceed 90% of taxable income unless the Asset Coverage Ratio requirement is met.
- Redemption: The Company may redeem the Notes in whole or in part on or after March 9, 2024, at 100% of the principal amount plus accrued interest.
Outlook, Risks, and Unusual Items
The Notes were approved for listing on the NYSE American LLC under the ticker symbol "SCCE" and began trading on or about March 10, 2022. The filing does not provide specific forward-looking guidance on revenue or earnings, nor does it detail specific risks beyond the standard indenture provisions and the structural subordination of the debt. The transaction was executed pursuant to a shelf registration statement (Form S-3) declared effective on February 25, 2022.
Investor Verification Checklist
- Verify the final amount of the overallotment option exercised by underwriters (up to $7.5 million).
- Confirm the exact net proceeds received after all offering expenses are finalized.
- Review the Company's current Asset Coverage Ratio to assess compliance with the 150% covenant for future dividends or debt incurrence.
- Examine the full text of the Fifth Supplemental Indenture (Exhibit 4.1) for specific events of default and cure provisions.
- Check subsequent filings for the use of proceeds from the $48.2 million raised.